Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
Memorial Sloan Kettering Cancer CenterZuckerman Research Center 417 East 68th Street
NOVEMBER 1-2 NEW YORK, NY
CONTEMPORARY MANAGEMENT OF
COMPLEX SKIN CANCERS2019
The purpose of this course is to provide the attendee with a multidisciplinary management approach for patients with skin cancer, including basal cell carcinoma, squamous cell carcinoma, merkel cell carcinoma, melanoma and other complex skin cancers. The topics will focus on advances in epidemiology, pathology and imaging, medical and surgical management and radiation therapy. Complex skin cancer cases will be presented and discussed in a tumor board style with a multidisciplinary panel of experts.
The target audience includes physicians and allied health professionals, who care for patients with skin cancer, including dermatologists, surgical and medical oncologists, otolaryngologists, ophthalmologists, general surgeons, plastic surgeons, pathologists and radiation oncologists.
Learning Objectives
• Describe melanoma and non melanoma skin cancer incidence and behavior• Define factors contributing to behavior and outcome of skin cancers• Define characteristics of skin cancers that require aggressive treatment• Understand benefits, limitations, and integration of different modalities
used in the treatment of skin• Review novel approaches to optimize surgical treatment of skin cancers• Assess role and variety of radiotherapeutic approaches to complex
skin cancers• Review role of biological therapy in the treatment of advanced skin cancers• Examine the optimal approaches toward reconstruction of defects
resulting from resection of skin
Kishwer S. Nehal, MDDirector, Mohs Micrographic and Dermatologic SurgeryAttending Physician, Dermatology ServiceDepartment of Medicine
MSK Course Directors
mskcc.org/skincancercourse
Reflectance Confocal Microscopy Workshop (Optional)*
Friday, November 1 4:45–5:45 pmWorkshop Space is Limited (pre-registration required)
Reflectance confocal microscopy (RCM) is a non-invasive device that images skin lesions at high resolution in vivo similar to traditional pathology. RCM has shown high sensitivity and specificity for detection of skin cancers (melanocytic and non-melanocytic). RCM has recently been granted Category I Current Procedural Terminology (CPT) reimbursement codes by the Centers for Medicare and Medicaid Services. RCM is now advancing as an add-on diagnostic tool to dermoscopy in clinics in the US, for early detection of skin cancers, while sparing un-necessary benign diagnosis. To expand RCM role in the clinical practice, there is a need for training a new generation of physicians - the future Confocalists.
*CME credit will not be offered for the Reflectance Confocal Microscopy Workshop.
Bhuvanesh Singh, MD, PhDDirector, Laboratory of Epithelial Cancer BiologyAttending Surgeon, Head & Neck ServiceDepartment of Surgery
Chrysalyne D. Schmults, MD, MSCEAssociate Professor of DermatologyHarvard Medical SchoolDirector, Mohs and Dermatologic Surgery CenterBrigham and Women’s Faulkner Hospital/Dana-Farber Cancer InstituteBoston, MA
Invited Course Faculty
MSK Course Faculty
Charlotte E. Ariyan, MD, PhDAssociate Attending Surgeon Gastric and Mixed Tumor ServiceDivision of General Surgical OncologyDepartment of Surgery
Christopher A. Barker, MDDirector of Clinical InvestigationAssistant Attending Radiation OncologistDepartment of Radiation Oncology
Edmund K. Bartlett, MDAssistant Attending SurgeonDepartment of Surgery
Danielle Bello, MDAssistant Attending SurgeonDepartment of Surgery
Klaus J. Busam, MDAttending PathologistSurgical Pathology ServiceDepartment of Pathology
Daniel G. Coit, MD, FACSAttending SurgeonGastric and Mixed Tumor ServiceDivision of General Surgical Oncology
Jennifer R. Cracchiolo, MDAssistant Attending SurgeonHead and Neck Service
Lara A. Dunn, MDAssistant AttendingHead and Neck Oncology ServiceDepartment of Medicine
Jasmine H. Francis, MDAssistant AttendingOphthalmic Oncology ServiceDepartment of Surgery
Manu Jain, MDOptical Imaging SpecialistDermatology ServiceDepartment of Medicine
Laura Leddy, MDAssistant Attending SurgeonUrology Service
Erica H. Lee, MDAssistant AttendingDermatology ServiceDepartment of Medicine
Cecilia Lezcano, MDAssistant Attending PathologistDepartment of Pathology
Michael A. Marchetti, MDAssistant AttendingDermatology ServiceDepartment of Medicine
Evan Matros, MD, MMScAssociate Attending SurgeonPlastic and Reconstructive ServiceDepartment of Surgery
Melissa P. Pulitzer, MDAssociate Attending PathologistSurgical Pathology ServiceDepartment of Pathology
Milind Rajadhyaksha, PhDOptical EngineerDermatology ServiceDepartment of Medicine
Anthony Rossi, MDAssistant Attending Dermatology serviceDepartment of Medicine
Veronica Rotemberg, MD, PhDAssistant Attending Dermatology ServiceDepartment of Medicine
Alison Betof Warner, MD, PhDAssistant Attending in MedicineMelanoma Service
CONTEMPORARY MANAGEMENT OF COMPLEX SKIN CANCERS
Breakfast and Registration 7:30 am
Introduction and Welcome Kishwer S. Nehal, MD and Bhuvanesh Singh, MD, PhD
8:00 am
BASAL CELL CARCINOMA MODERATOR: Kishwer S. Nehal, MD
2019 Hot Topics Anthony Rossi, MD 8:10 am
Debate - Locally Advanced BCC • Surgery Chrysalyne Schmults, MD, MSCE
• Radiation Christopher Barker, MD
• Hedgehog Pathway Inhibitor Lara Dunn, MD
Q&A
8:25 am
8:30 am
8:50 am
9:05 am
9:20 am
Tumor Board: BCCMultidisciplinary Challenging Cases (Audience Response Session; Q&A) All Faculty
9:30 am
Break 10:30
PREVENTION AND QUALITY OF LIFE MODERATOR: Erica Lee, MD
Debate - Role of Prevention Strategies • Yes Chrysalyne Schmults, MD, MSCE
• No Michael Marchetti, MD
Prevention in High-Risk Patients Veronica Rotemberg, MD
Q&A
10:45 am
10:50 am
11:10 am
11:25 am
11:40 am
Development of Patient Reported Outcome Measures Evan Matros, MD 11:50 am
Patient Outcomes in Dermatologic Surgery Erica Lee, MD 12:00 pm
Q&A 12:20 pm
Lunch Break 12:30 pm
SQUAMOUS CELL CARCINOMAMODERATOR: Bhuvanesh Singh, MD, PhD
2019 Update Chrysalyne Schmults, MD, MSCE 1:45 pm
Debate - Role of Adjuvant Radiation in the Management of Perineural Invasion• Yes Christopher Barker, MD
• No Jennifer Cracchiolo, MD
2:15 pm
Management of Nodal Metastasis Bhuvanesh Singh, MD 2:45 pm
Video: Facial Reconstruction Bhuvanesh Singh, MD 3:00 pm
Low-Risk SCC Conundrums Anthony Rossi, MD 3:15 pm
Tumor Board: SCCMultidisciplinary Challenging Cases (Audience Response Session; Q&A) All Faculty
3:30 pm
Adjourn 4:30 pm
FRIDAY, NOVEMBER 1
Breakfast 8:00 am
MERKEL CELL CARCINOMAMODERATOR: Christopher Barker, MD
Pathologic Assessment of Merkel Cell Carcinoma Melissa Pulitzer, MD
8:30 am
Controversies in the Management of Stage III Merkel Cell Carcinoma Daniel Coit, MD and Christopher Barker, MD
8:50 am
Tumor Board: MCCMultidisciplinary Challenging Cases (Audience Response Session; Q&A) All Faculty
9:30 am
Break 10:00
COMPLEX SKIN MALIGNANCIESMODERATORS: Cecilia Lezcano, MD and Klaus Busam, MD
Eyelid Malignancies Jasmine Francis, MD 10:15 am
Q&A 10:45 am
GU Skin Malignancies Anthony Rossi, MD 10:50 am
GU Workup and Urologic Reconstruction Laura Leddy, MD 11:15 am
Q&A 11:40 am
Dermatofibrosarcoma Protuberans Kishwer Nehal, MD 11:50 am
Microcystic Adnexal Carcinoma Chrysalyne Schmults, MD 12:05 pm
Q&A 12:20 pm
Lunch Break 12:30 pm
MELANOMAMODERATOR: Charlotte Ariyan, MD, PhD
Update on Surgical Margins and Lymph Nodes in Melanoma Danielle Bello, MD 1:30 pm
Primary Tumor Profiling in Early Melanoma Michael Marchetti, MD 1:50 pm
Primary Tumor Profiling in Advanced Melanoma Edmund Bartlett, MD 2:10 pm
Who Gets Adjuvant Therapy in Melanoma? Allison Betof Warner, MD, PhD 2:30 pm
Q&A 2:50 pm
Tumor Board: MelanomaMultidisciplinary Challenging Cases (Audience Response Session; Q&A) All Faculty
3:00 pm
Adjourn 4:00 pm
Join the conversation:#MSKskincancerCME@MSKCME
SATURDAY, NOVEMBER 2
Reflectance Confocal Microscopy Workshop (Optional)*Anthony Rossi, MD, Milind Rajadhyaksha, MD, and Manu Jain, MD
4:45 pm - 5:45 pm
*Reflectance confocal microscopy (RCM) is a non-invasive device that images skin lesions at high resolution in vivo similar to traditional pathology. Pre-registration is required for the workshop and space is limited. CME credit will not be offered for the Reflectance Confocal Microscopy Workshop.
Register online:
mskcc.org/skincancercourseCourse registration includes continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.
Registration Discounts/Promotions
• MSK Alumni, MSK Cancer Alliance and Cancer Care Partner Discounts Available. Please contact [email protected] for more information or a promotion code.
• Complimentary Registration for MSK Employees. However, you must complete course registration in order to attend this course.
*Early Registration Expires September 15, 2019**Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.
w: mskcc.org/cmee: [email protected]
For course details and registration:
mskcc.org/cme
REGISTRATION FEES EARLY* GENERAL
Physicians (MDs, PhDs & DOs) $475 $550
Advanced Practice Providers $375 $450
Residents, Fellows, Nurses & Other Healthcare Providers $125 $200
Industry Professionals** $900 $975
15th Annual Dermoscopy Intermediate Course
COURSE DIRECTORS
Ashfaq A. Marghoob, MD (MSK)Michael A. Marchetti, MD (MSK)Harold S. Rabinovitz, MD (Univ. of Miami)
On-site attendance for this course is currently closed as we have reached capacity. We are pleased to offer a live simulcast option. CME Credit will still be offered for the live simulcast and active participation is encouraged through online Q&A.
2nd Annual Basic Course in Reflectance Confocal Microscopy: Non-Invasive Diagnosis of Skin Cancer
MSK COURSE DIRECTORS
Manu Jain, MDAnthony Rossi, MD
Space is very limited for this course; early registration encouraged.
Transforming Dermatology in the Digital Era
MSK COURSE DIRECTORS
Allan Halpern, MD, MS Steven Q. Wang, MD
SEPTEMBER
22
OCTOBER
31
MSK CME 2019Dermatology Courses
Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation StatementMemorial Sloan Kettering Cancer Center designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty Disclosure It is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it provides as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity provided by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.
Accreditation
MSK has negotiated special rates and amenities at select hotels in Manhattan. For more information, visit: mskcc.org/cme
SEPTEMBER
20-21
REGISTRATION